Table 1.
American Urological Association | European Urologic Association |
---|---|
• Carcinoma in situ • High-grade T1 tumors • Recurrent or multifocal or large (> 3 cm) high-grade Ta tumors • Any tumor following BCG failure • Lymphovascular invasion or non-urothelial histology • High-grade tumor involving prostatic urethra |
• Carcinoma in situ • Any high-grade tumor • Any T1 tumor • Multiple, recurrent, and large low-grade Ta tumors |
Highest risk: • T1 HG with CIS • Multiple, large, or recurrent T1 high-grade tumors • T1 with CIS in prostatic urethra • Some variant histology or lymphovascular invasion |